Plasma Phthalate Levels in Pubertal Gynecomastia

durmaz E., ÖZMERT E. N. , ERKEKOGLU P., Giray B., Derman O. , Hincal F. , ...Daha Fazla

PEDIATRICS, cilt.125, 2010 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 125 Konu: 1
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1542/peds.2009-0724
  • Dergi Adı: PEDIATRICS


OBJECTIVE: Several untoward health effects of phthalates, which are a group of industrial chemicals with many commercial uses including personal-care products and plastic materials, have been defined. The most commonly used, di-(2-ethylhexyl)-phthalate (DEHP), is known to have antiandrogenic or estrogenic effects or both. Mono-(2-ethylhexyl)-phthalate (MEHP) is the main metabolite of DEHP. In this study, we aimed to determine the plasma DEHP and MEHP levels in pubertal gynecomastia cases.